These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16889447)

  • 1. Evaluation of an interchangeability switch in patients treated with clozapine: A retrospective review.
    Alessi-Severini S; Honcharik PL; Simpson KD; Eleff MK; Collins DM
    J Clin Psychiatry; 2006 Jul; 67(7):1047-54. PubMed ID: 16889447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation.
    Mofsen R; Balter J
    Clin Ther; 2001 Oct; 23(10):1720-31. PubMed ID: 11726006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting from brand-name to generic clozapine: a review of effectiveness and tolerability data.
    Bobo WV; Stovall JA; Knostman M; Koestner J; Shelton RC
    Am J Health Syst Pharm; 2010 Jan; 67(1):27-37. PubMed ID: 20044366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converting patients from brand-name clozapine to generic clozapine.
    Sajbel TA; Carter GW; Wiley RB
    Ann Pharmacother; 2001 Mar; 35(3):281-4. PubMed ID: 11261523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
    Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K
    J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does therapeutic equivalence follow bioequivalence? A randomized trial to assess clinical effects after switching from Clozaril to generic clozapine (gen-clozapine).
    Oluboka O; Stewart S; Landry S; Adams S
    J Clin Pharmacol; 2010 May; 50(5):531-5. PubMed ID: 20089825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bioequivalence between generic and brand-name clozapine in Chinese schizophrenic patients: A randomized, two-period, crossover study.
    Yang X; Yan Q; Yang L; Li J; Fan X; Chen J; Wu H; Cai H; Zhu R; Fang P
    Int J Clin Pharmacol Ther; 2021 Aug; 59(8):578-584. PubMed ID: 34142950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching clozapine responders to olanzapine.
    Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
    J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
    Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
    J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
    Hsu CW; Lee SY; Wang LJ
    Schizophr Res; 2018 Mar; 193():107-113. PubMed ID: 28629889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychopharmacology. Clozapine and agranulocytosis.
    Feldman J
    Psychiatr Serv; 1996 Nov; 47(11):1177-8. PubMed ID: 8916231
    [No Abstract]   [Full Text] [Related]  

  • 15. The European experience with use of clozapine.
    Naber D; Hippius H
    Hosp Community Psychiatry; 1990 Aug; 41(8):886-90. PubMed ID: 1976107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    Schooler NR; Marder SR; Chengappa KN; Petrides G; Ames D; Wirshing WC; McMeniman M; Baker RW; Parepally H; Umbricht D; Kane JM
    J Clin Psychiatry; 2016 May; 77(5):628-34. PubMed ID: 27035871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a relationship between clozapine and obsessive-compulsive disorder?: a retrospective chart review.
    Ghaemi SN; Zarate CA; Popli AP; Pillay SS; Cole JO
    Compr Psychiatry; 1995; 36(4):267-70. PubMed ID: 7554870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
    Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcomes Following a Switch From a Brand to an Authorized Versus Independent Generic Drug.
    Hansen RA; Qian J; Berg RL; Linneman JG; Seoane-Vazquez E; Dutcher S; Raofi S; Page CD; Peissig PL
    Clin Pharmacol Ther; 2018 Feb; 103(2):310-317. PubMed ID: 27981563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.